DiscoverBloomberg SurveillanceSurveillance: Building Vaccine Capacity With CureVac CEO
Surveillance: Building Vaccine Capacity With CureVac CEO

Surveillance: Building Vaccine Capacity With CureVac CEO

Update: 2020-11-18
Share

Description

Gabriela Santos, JPMorgan Asset Management Global Market Strategist, says the stars are aligning for a broader set of emerging markets. Michael Kushma, Morgan Stanley Investment Management CIO of Global Fixed Income, says the Fed has been clear about its intentions to support the economy. Dean Curnutt, Macro Risk Advisors CEO, reminds investors to be prepared for the unexpected as 2020 nears its end. Franz-Werner Haas, CureVac CEO, says there will be enough capacity to vaccinate the world until the end of next year.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Surveillance: Building Vaccine Capacity With CureVac CEO

Surveillance: Building Vaccine Capacity With CureVac CEO

Bloomberg Radio